Premium
Malignant tumors of the testis: Analysis of treatment results and sites and causes of failure
Author(s) -
Quivey Jeanne M.,
Fu Karen K.,
Herzog Karen A.,
Weiss Jerome M.,
Phillips Theodore L.
Publication year - 1977
Publication title -
cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.052
H-Index - 304
eISSN - 1097-0142
pISSN - 0008-543X
DOI - 10.1002/1097-0142(197703)39:3<1247::aid-cncr2820390334>3.0.co;2-e
Subject(s) - medicine , seminoma , choriocarcinoma , orchiectomy , supraclavicular lymph nodes , lymph , carcinoma , lung , surgery , dysgerminoma , chemotherapy , cancer , pathology , metastasis , ovary
A total of 150 patients with germinal testicular neoplasms treated at the University of California, San Francisco, were reviewed. The 5‐year actuarial survival rate was 95% for 57 patients with seminoma and 56% for 75 patients with carcinoma. Treatment modalities were compared with respect to sites and causes of failure and complications. The most common sites of failure in the carcinoma patients were lung, and supraclavicular or mediastinal lymph nodes. Scrotal orchiectomy, elevated gonadotropins, elements of choriocarcinoma, and bulky abdominal disease were all correlated with high treatment failure rate.